Marloes Grobben

882 total citations
18 papers, 135 citations indexed

About

Marloes Grobben is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Infectious Diseases. According to data from OpenAlex, Marloes Grobben has authored 18 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Immunology and 7 papers in Infectious Diseases. Recurrent topics in Marloes Grobben's work include Monoclonal and Polyclonal Antibodies Research (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and HIV Research and Treatment (5 papers). Marloes Grobben is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and HIV Research and Treatment (5 papers). Marloes Grobben collaborates with scholars based in Netherlands, United States and Canada. Marloes Grobben's co-authors include Marit J. van Gils, Meliawati Poniman, Rogier W. Sanders, Judith A. Burger, Johannes B. van Goudoever, Neeltje A. Kootstra, Britt J. van Keulen, Steven W. de Taeye, Christianne J.M. de Groot and Gestur Vidarsson and has published in prestigious journals such as Gut, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Marloes Grobben

16 papers receiving 135 citations

Peers

Marloes Grobben
Joshua D. Amos United States
Paola Martinez-Murillo United States
Thaddeus C. Gurley United States
Glenda Canderan United States
Mathieu Claireaux Netherlands
Samuel Lebourgeois France
Bob C. Lin United States
Alex Farina Switzerland
Kristin Narayan United States
Jacob Berrigan United States
Joshua D. Amos United States
Marloes Grobben
Citations per year, relative to Marloes Grobben Marloes Grobben (= 1×) peers Joshua D. Amos

Countries citing papers authored by Marloes Grobben

Since Specialization
Citations

This map shows the geographic impact of Marloes Grobben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marloes Grobben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marloes Grobben more than expected).

Fields of papers citing papers by Marloes Grobben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marloes Grobben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marloes Grobben. The network helps show where Marloes Grobben may publish in the future.

Co-authorship network of co-authors of Marloes Grobben

This figure shows the co-authorship network connecting the top 25 collaborators of Marloes Grobben. A scholar is included among the top collaborators of Marloes Grobben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marloes Grobben. Marloes Grobben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Grobben, Marloes, Karlijn van der Straten, Nathalie Dereuddre‐Bosquet, et al.. (2025). Induction of HIV-1-specific antibody-mediated effector functions by native-like envelope trimers in humans. PLoS Pathogens. 21(10). e1013614–e1013614.
2.
Boyd, Anders, Marloes Grobben, Sylvie M. Koekkoek, et al.. (2025). Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohort. Gut. gutjnl–2025.
3.
Taeye, Steven W. de, Jeffrey C. Umotoy, Marloes Grobben, et al.. (2024). Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing. Communications Biology. 7(1). 964–964. 7 indexed citations
4.
Grobben, Marloes, Sylvie M. Koekkoek, Stefan Slamanig, et al.. (2024). A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns. Virus Research. 341. 199308–199308. 3 indexed citations
5.
Grobben, Marloes, Margreet Bakker, Jeffrey C. Umotoy, et al.. (2024). Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression. PLoS Pathogens. 20(12). e1012739–e1012739. 3 indexed citations
6.
Guerra, Denise, Gius Kerster, Mathieu Claireaux, et al.. (2024). Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses. PLoS Pathogens. 20(8). e1012453–e1012453. 1 indexed citations
7.
Brinkkemper, Mitch, Meliawati Poniman, Tom P. L. Bijl, et al.. (2024). A spike virosome vaccine induces pan-sarbecovirus antibody responses in mice. iScience. 27(5). 109719–109719. 1 indexed citations
8.
Leeuwen, Leanne P. M. van, Marloes Grobben, Marit J. van Gils, et al.. (2024). Simultaneous Protein Quantitation and Glycosylation Profiling of Antigen-Specific Immunoglobulin G1 in Large Clinical Studies. Journal of Proteome Research. 23(12). 5600–5605. 1 indexed citations
9.
Bende, Richard J., Thera A.M. Wormhoudt, Marloes Grobben, et al.. (2024). Distinct groups of autoantigens as drivers of ocular adnexal MALT lymphoma pathogenesis. Life Science Alliance. 7(9). e202402841–e202402841. 2 indexed citations
10.
Leeuwen, Leanne P. M. van, Marloes Grobben, Corine H. GeurtsvanKessel, et al.. (2024). Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program. Frontiers in Immunology. 15. 1390022–1390022. 5 indexed citations
11.
Groot, Christianne J.M. de, Marloes Grobben, Sharon Remmelzwaal, et al.. (2023). Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonate. International Journal of Infectious Diseases. 130. 126–135. 13 indexed citations
12.
Grobben, Marloes, Merijn W. Bijlsma, Sophie Cohen, et al.. (2022). Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children. Frontiers in Immunology. 13. 976382–976382. 4 indexed citations
13.
Haaren, Marlies M. van, Meliawati Poniman, Gillian Dekkers, et al.. (2022). Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions. Frontiers in Immunology. 13. 893648–893648. 20 indexed citations
14.
Grobben, Marloes, Arthur W. D. Edridge, Maarten F. Jebbink, et al.. (2022). Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections. Frontiers in Microbiology. 13. 853410–853410. 8 indexed citations
15.
Velden, Yme U. van der, Marloes Grobben, Tom G. Caniels, et al.. (2022). A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike. Scientific Reports. 12(1). 3884–3884. 11 indexed citations
16.
Grobben, Marloes, Karlijn van der Straten, A. H. Ayesha Lavell, et al.. (2022). Decreased Passive Immunity to Respiratory Viruses through Human Milk during the COVID-19 Pandemic. Microbiology Spectrum. 10(4). e0040522–e0040522. 16 indexed citations
17.
Brinkkemper, Mitch, Philip J. M. Brouwer, Pauline Maisonnasse, et al.. (2021). A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern. npj Vaccines. 6(1). 146–146. 8 indexed citations
18.
Grobben, Marloes, et al.. (2019). The potential of engineered antibodies for HIV-1 therapy and cure. Current Opinion in Virology. 38. 70–80. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joshua D. Amos Breakdown of academic impact, for papers by Paola Martinez-Murillo Breakdown of academic impact, for papers by Thaddeus C. Gurley Breakdown of academic impact, for papers by Glenda Canderan Breakdown of academic impact, for papers by Mathieu Claireaux Breakdown of academic impact, for papers by Samuel Lebourgeois Breakdown of academic impact, for papers by Bob C. Lin Breakdown of academic impact, for papers by Alex Farina Breakdown of academic impact, for papers by Kristin Narayan Breakdown of academic impact, for papers by Jacob Berrigan
Rankless by CCL
2026